-
Lysophosphatidylinositol (LPI, lysoPI), or L-α-
lysophosphatidylinositol, is an
endogenous lysophospholipid and
endocannabinoid neurotransmitter. LPI,...
- the brain, but 2- to 9-fold
higher concentrations peripherally.
Lysophosphatidylinositol is the
endogenous ligand to
novel endocannabinoid receptor GPR55...
-
Recent research suggests that
lysophosphatidylinositol and its 2-arachidonoyl derivative, 2-arachidonoyl
lysophosphatidylinositol (2-ALPI), may be the endogenous...
- 2-Arachidonoyl
lysophosphatidylinositol (2-ALPI) N-Arachidonoyl
serotonin (AA-5-HT)
Docosatetraenoylethanolamide (DEA)
Lysophosphatidylinositol (LPI) Oleamide...
-
effects of THC. THCV also acts as an
agonist of GPR55 and l-α-
lysophosphatidylinositol (LPI), and
beyond the
endocannabinoid system, THCV also activate...
- 2-Arachidonoyl
lysophosphatidylinositol (2-ALPI) N-Arachidonoyl
serotonin (AA-5-HT)
Docosatetraenoylethanolamide (DEA)
Lysophosphatidylinositol (LPI) Oleamide...
- AM-251 CID1011163 CID1252842 CID1792579 CP 55,940 GSK-494581A
Lysophosphatidylinositol ML-184 ML-185 ML-186 O-1602
Oleoylethanolamide Palmitoylethanolamide...
- AM-251 CID1011163 CID1252842 CID1792579 CP 55,940 GSK-494581A
Lysophosphatidylinositol ML-184 ML-185 ML-186 O-1602
Oleoylethanolamide Palmitoylethanolamide...
- 2-Arachidonoyl
lysophosphatidylinositol (2-ALPI) N-Arachidonoyl
serotonin (AA-5-HT)
Docosatetraenoylethanolamide (DEA)
Lysophosphatidylinositol (LPI) Oleamide...
- 2-Arachidonoyl
lysophosphatidylinositol (2-ALPI) N-Arachidonoyl
serotonin (AA-5-HT)
Docosatetraenoylethanolamide (DEA)
Lysophosphatidylinositol (LPI) Oleamide...
